Email Trove From US FDA Shows Peter Marks As Champion For Plasma Authorization

 
• By Sarah Karlin-Smith
  
FDA’s authorization of convalescent plasma has been one of the agency’s most controversial decisions during COVID-19 • Source: Nielsen Hobbs for Informa| Alamy, FDA images

More from Agency Leadership

More from Pink Sheet